These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 19588687)

  • 1. Antenatal diagnosis of Down syndrome: how good is state of the art.
    Mittal R; Varghese RM; Puliyel JM
    J Indian Med Assoc; 2009 Jan; 107(1):36, 38-40. PubMed ID: 19588687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Application of fluorescence in situ hybridization to prenatal diagnosis of Down syndrome].
    Wang M; Li QF; Qiao FY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Jun; 22(3):317-9. PubMed ID: 15952125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antenatal screening for Down syndrome.
    Wald NJ
    Prog Clin Biol Res; 1995; 393():27-42. PubMed ID: 8545455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal detection of isochromosome 21 by QF-PCR. A comparison between FISH and traditional karyotyping.
    Gole L; Lian NB; Lian NP; Rauff M; Biswas A; Choolani M
    Fetal Diagn Ther; 2008; 24(1):47-50. PubMed ID: 18504381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costs and effects of prenatal screening methods for Down syndrome and neural tube defects.
    Hoogendoorn M; Evers SM; Schielen PC; van Genugten ML; de Wit GA; Ament AJ
    Community Genet; 2008; 11(6):359-67. PubMed ID: 18690004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. False-positive diagnosis of trisomy 21 using fluorescence in situ hybridisation (FISH) on uncultured amniotic fluid cells.
    George AM; Oei P; Winship I
    Prenat Diagn; 2003 Apr; 23(4):302-5. PubMed ID: 12673634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Early ultrasonic amniocentesis. 147 cases].
    Darconza G; Paradiso S; Trentadue R
    Minerva Ginecol; 1990 Mar; 42(3):55-8. PubMed ID: 2140149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prenatal investigations for Down's syndrome: medical-technical considerations and dilemmas arising from current screening methods].
    Grijseels EW; Laudy JA; Galjaard RJ; Wildschut HI
    Ned Tijdschr Geneeskd; 2004 Oct; 148(44):2166-71. PubMed ID: 15559409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid aneuploidy screening (FISH or QF-PCR): the changing scene in prenatal diagnosis?
    Leung WC; Lau ET; Lao TT; Tang MH
    Expert Rev Mol Diagn; 2004 May; 4(3):333-7. PubMed ID: 15137900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimized criteria for using fluorescence in situ hybridization in the prenatal diagnosis of common aneuploidies.
    Leclercq S; Lebbar A; Grange G; Tsatsaris V; Le Tessier D; Dupont JM
    Prenat Diagn; 2008 Apr; 28(4):313-8. PubMed ID: 18306148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Non-invasive prenatal diagnosis of fetal Down syndrome by dual-color fluorescence in situ hybridization with co-denaturation].
    Wang H; Li Y; Wang D
    Zhonghua Fu Chan Ke Za Zhi; 2001 Jun; 36(6):338-40. PubMed ID: 11783130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal cfDNA screening for Down syndrome--a cost sensitivity analysis.
    Cuckle H; Benn P; Pergament E
    Prenat Diagn; 2013 Jul; 33(7):636-42. PubMed ID: 23674341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individualized choice in prenatal diagnosis: the impact of karyotyping and standalone rapid aneuploidy detection on quality of life.
    Boormans EM; Birnie E; Oepkes D; Boekkooi PF; Bonsel GJ; van Lith JM;
    Prenat Diagn; 2010 Oct; 30(10):928-36. PubMed ID: 20730751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular biology usefulness for rapid diagnosis of Down's syndrome and common aneuploidies].
    Fauret AL; Bilan F; Patri S; Couet D; Marechaud M; Pierre F; Gilbert-Dussardier B; Kitzis A
    Gynecol Obstet Fertil; 2009; 37(7-8):611-9. PubMed ID: 19574080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnancies conceived using assisted reproductive technologies (ART) have low levels of pregnancy-associated plasma protein-A (PAPP-A) leading to a high rate of false-positive results in first trimester screening for Down syndrome.
    Amor DJ; Xu JX; Halliday JL; Francis I; Healy DL; Breheny S; Baker HW; Jaques AM
    Hum Reprod; 2009 Jun; 24(6):1330-8. PubMed ID: 19246467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ductus venosus pulsatility index as an antenatal screening marker for Down's syndrome: use with the Combined and Integrated tests.
    Borrell A; Borobio V; Bestwick JP; Wald NJ
    J Med Screen; 2009; 16(3):112-8. PubMed ID: 19805751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-invasive prenatal diagnosis for Down syndrome: the paradigm will shift, but slowly.
    Benn P; Cuckle H; Pergament E
    Ultrasound Obstet Gynecol; 2012 Feb; 39(2):127-30. PubMed ID: 22278776
    [No Abstract]   [Full Text] [Related]  

  • 18. Accuracy of the clinical diagnosis of Down syndrome.
    Devlin L; Morrison PJ
    Ulster Med J; 2004 May; 73(1):4-12. PubMed ID: 15244118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid testing versus karyotyping in Down's syndrome screening: cost-effectiveness and detection of clinically significant chromosome abnormalities.
    Gekas J; van den Berg DG; Durand A; Vallée M; Wildschut HI; Bujold E; Forest JC; Rousseau F; Reinharz D
    Eur J Hum Genet; 2011 Jan; 19(1):3-9. PubMed ID: 20842178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Which prenatal screening protocol?
    Ferguson-Smith MA
    Prenat Diagn; 2004 Oct; 24(10):761. PubMed ID: 15503274
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.